Kimberly-Clark cuts annual forecasts as China quality claims hurt diaper sales
KMB•Quarterly results
Last month, Kimberly-Clark finalized a 51% stake sale in its international tissue business to Suzano SUZB3.SA, creating the $3.4 billion Arbex joint venture to compete with rivals Procter & Gamble PG.N and Essity.
Net sales rose 0.6% to $4.19 billion in the quarter, below analysts' $4.22 billion estimate, while adjusted operating profit increased 6.2% to $757 million, helped by tariff refunds of about $45 million.
China disruption offsets broader progress
Kimberly-Clark COO Russ Torres labeled the China disruption a "one-time external impact," expected to reduce organic growth in its International Personal Care segment by three to four percentage points and hold back operating profit growth by 10 to 12 percentage points this year, as the company "aggressively" invests to defend its franchise.




